BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ELL, P55199, 8178, ENSG00000105656, ELL1, C19orf17
16 results:

  • 1. Rare
    Panagopoulos I; Andersen K; Eilert-Olsen M; Rognlien AG; Munthe-Kaas MC; Micci F; Heim S
    Cancer Genomics Proteomics; 2021; 18(2):121-131. PubMed ID: 33608309
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia.
    Juul-Dam KL; Ommen HB; Nyvold CG; Walter C; Vålerhaugen H; Kairisto V; Abrahamsson J; Alm SJ; Jahnukainen K; Lausen B; Reinhardt D; Zeller B; von Neuhoff N; Fogelstrand L; Hasle H
    Br J Haematol; 2020 Jul; 190(2):198-208. PubMed ID: 32175599
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Rare myeloid sarcoma with KMT2A (MLL)-ell fusion presenting as a vaginal wall mass.
    Bao H; Gao J; Chen YH; Altman JK; Frankfurt O; Wilson AL; Sukhanova M; Chen Q; Lu X
    Diagn Pathol; 2019 Mar; 14(1):26. PubMed ID: 30922345
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Downregulation of microRNA-15a-3p is correlated with clinical outcome and negatively regulates cancer proliferation and migration in human osteosarcoma.
    Shi J; Fu Q; Yang P; Liu H; Ji L; Wang K
    J Cell Biochem; 2018 Jan; 119(1):1215-1222. PubMed ID: 28722268
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Reemergence of translocation t(11;19)(q23;p13.1) in the absence of clinically overt leukemia.
    Uemura S; Tamura A; Saito A; Hasegawa D; Nino N; Yokoi T; Tahara T; Kozaki A; Kishimoto K; Ishida T; Kawasaki K; Mori T; Nishimura N; Ishimae M; Eguchi M; Kosaka Y
    Int J Hematol; 2017 Dec; 106(6):847-851. PubMed ID: 28669059
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells.
    Shah CA; Bei L; Wang H; Altman JK; Platanias LC; Eklund EA
    Oncotarget; 2016 Aug; 7(34):54782-54794. PubMed ID: 27340869
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Expression and prognostic significance of ell-associated factor 2 in human prostate cancer.
    Zang Y; Dong Y; Yang D; Xue B; Li F; Gu P; Zhao H; Wang S; Zhou S; Ying R; Wang Z; Shan Y
    Int Urol Nephrol; 2016 May; 48(5):695-700. PubMed ID: 26895851
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror.
    Waning DL; Mohammad KS; Guise TA
    Cancer Cell; 2013 Oct; 24(4):407-9. PubMed ID: 24135278
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Complex three-way translocation involving MLL, ell, RREB1, and CMAHP genes in an infant with acute myeloid leukemia and t(6;19;11)(p22.2;p13.1;q23.3).
    Tuborgh A; Meyer C; Marschalek R; Preiss B; Hasle H; Kjeldsen E
    Cytogenet Genome Res; 2013; 141(1):7-15. PubMed ID: 23735562
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The presence of mature granulocytes/monocytes derived from leukemic cells in MLL-associated leukemia.
    Kobayashi S; Obata M; Hagihara M; Motohashi K; Ito S; Ohshima R; Sakai R; Maruta A; Kanamori H
    Int J Hematol; 2009 Dec; 90(5):591-596. PubMed ID: 19936877
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Neonatal acute myeloid leukemia in an infant whose mother was exposed to diethylstilboestrol in utero.
    Chantrain CF; Sauvage D; Brichard B; Dupont S; Poirel HA; Ameye G; De Weer A; Vandenberghe P; Detaille T; Anslot C; de Cléty SC; Vermylen C
    Pediatr Blood Cancer; 2009 Aug; 53(2):220-2. PubMed ID: 19405140
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel variant form of MLL-ell fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.
    Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Translocation (8;12)(q13;p13) during disease progression in acute myelomonocytic leukemia with t(11;19)(q23;p13.1).
    Yamamoto K; Nagata K; Tsurukubo Y; Inagaki K; Ono R; Taki T; Hayashi Y; Hamaguchi H
    Cancer Genet Cytogenet; 2002 Aug; 137(1):64-7. PubMed ID: 12377416
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Characterization of t(11;19)(q23;p13.3) by fluorescence in situ hybridization analysis in a pediatric patient with therapy-related acute myelogenous leukemia.
    Cheng L; Ramesh KH; Radel E; Ratech H; Wei D; Cannizzaro LA
    Cancer Genet Cytogenet; 2001 Aug; 129(1):17-22. PubMed ID: 11520560
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A comparative study of nuclear morphometry and proliferating activity in neuroectodermal tumors of bone and Ewing's sarcoma of bone.
    Oda Y; Tsuneyoshi M
    Gen Diagn Pathol; 1995 Oct; 141(2):121-9. PubMed ID: 8548592
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Effect of calcitonin on body pains caused by bone metastases of urogenital cancer].
    Sugiyama T; Kohri K; Yachiku S; Kurita T
    Hinyokika Kiyo; 1983 Aug; 29(8):953-8. PubMed ID: 6675446
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.